In order to investigate the putative anti-emetic effect of propofol, 53 patients undergoing gynaecological laparoscopy were given a standard anaesthetic including induction with thiopentone. At the end of surgery, the patients received either a sub-anaesthetic does of propofol or an equivalent volume of normal saline. There was no difference in the incidence of nausea and vomiting between the propofol and control group. It is concluded that low-dose propofol does not have an anti-emetic effect.
Postoperative nausea and vomiting continues to be a common and distressing occurrence, especially following gynaecological surgery. The incidence of emetic sequelae is particularly high after laparoscopy (30-40%).1 Several factors appear to influence this, including the perioperative use of an opioid, the use of nitrous oxide and the choice of induction agent. I . 3 Propofol is associated with a reduced incidence of emetic sequelae and it has been suggested that it has an anti-emetic action. 2 ,3 We suspected that the reduced incidence of nausea and vomiting associated with propofol may be due to the avoidance of a barbiturate rather than a specific anti-emetic action. We have studied the anti-emetic effect of a sub-anaesthetic dose of propofol on patients receiving a barbiturate induction for laparoscopy. METHODS Sixty healthy women who were due to undergo elective laparoscopy were recruited into the trial. Patients of ASA grade greater than two and those known to be pregnant were excluded. Written informed consent was obtained from all patients. The patients were allocated into one of two groups using a random number sheet. The propofol group were to receive propofol 0.3 mg/kg at the completion of surgery and the control group an equivalent volume of normal saline. A standard anaesthetic was used which consisted of oral temazepam premedication, thiopentone induction, fentanyl 2 mcg/kg, nitrous oxide 60% in oxygen and isoflurance 0,5-1.0% for maintenance of anaesthesia and vecuronium 0,1 mg/kg for muscle relaxation. All patients also received glycopyrrolate 5 mcg/kg on induction and neostigmine 2.5 mg with atropine 1.0 mg at the end of surgery. The patients were monitored during anaesthesia with an ECG, pulse oximeter, capnograph and automatic blood pressure cuff. They were all ventilated to normocapnia. The blood pressure and heart rate were recorded immediately prior to and three minutes after the injection of the test drug. The reversal agents were not given until after the injection of the test drug. The reversal agents were not given until after the second blood pressure recording. Pethidine 1.0 mg/kg and metoclopramide 10 mg as required were prescribed for the postoperative period. Nursing staff were requested not to administer metoclopramide routinely with the pethidine, but only if clinically indicated by persistent nausea and vomiting. The incidence of nausea, vomiting and the administration of metoclopramide was recorded by the nursing staff in recovery and hourly on the ward for the next four hours. The nurses were unaware of which group the patients were in.
Results were analysed using the Chi-squared test with Yates correction for small numbers. A probability level of less than 5% (P < 0.05) was considered significant. This study was conducted at both the Gloucestershire Royal Hospital and at Southmead Hospital, Bristol, where ethical committee approval was obtained.
RESULTS
Of the 60 women recruited into the study, 29 received propofol, 24 received normal saline and seven were excluded from the trial due to either a change in the surgical procedure or anaesthetic technique or the unexpected operative finding of a pregnancy. The mean age, body mass index (weight/height squared in kglm2) and duration of surgery are shown in Table 1 . There was no significant difference between the groups. The mean arterial pressures before and after giving the test drug are shown in Table 2 . There was no difference between or within groups. The incidence of nausea, vomiting and the use of metoclopramide is shown in Table 3 . The overall incidence of nausea and vomiting was high in both groups, particularly in recovery. Eight in the propofol and ten in the control group experienced nausea in recovery. Four in the propofol and five in the control group vomited in recovery. Metoclopramide was administered to four of the propofol and six of the control group in recovery. There is no difference between the groups. The overall incidence of an emetic event (nausea and/or vomiting and/or metoclopramide) was 12 for the propofol and 15 for the control group. This difference is not statistically significant. DISCUSSION This study has demonstrated an incidence of emetic sequelae following laparoscopy of 40-60%. This is somewhat higher than reported by other workers, which may be due to the avoidance of an anti-emetic premedicant and to the use of nitrous oxide. 1, 4 The lack of anti-emetic effect in this study may be because the dose of propofol used was insufficient. Other workers have demonstrated a reduced incidence of nausea and vomiting when propofol is used for induction and maintenance of anaesthesia. McCollum et al. 2 found a significantly reduced incidence of emetic symptoms with a propofol/nitrous oxide anaesthetic. Gunawardene and White 3 found a reduced incidence of nausea and vomiting using propofol as the sole anaesthetic compared with a propofol/nitrous oxide/enflurane anaesthetic. Neither of these studies demonstrates a true anti-emetic effect and their results could be explained by the avoidance of another agent or by the improved speed and quality of recovery associated with a propofol anaesthetic. Most drugs with an established anti-emetic effect act at the chemoreceptor trigger zone (CTZ) as dopamine antagonists. They bear a structural similarity to GABA and have a propylene chain with at least one tertiary nitrogen atom and an aromatic ring. 5 Propofol has neither of these structural characteristics and is therefore unlikely to have a specific effect on the CTZ. Propofol is formulated in a 10% lipid emulsion and a recent study has demonstrated that this emulsion does not possess significant anti-emetic effect when given to patients undergoing a thiopentone/fentanyl! enflurane/nitrous oxide anaesthetic for gynaecological laparoscopy. 6 In conclusion, we have confirmed the high incidence of nausea and vomiting following laparoscopy. We have demonstrated that a subanaesthetic dose of propofol following a barbiturate induction does not have a significant anti-emetic effect.
